ATRA Price Targets and Analyst Ratings NASDAQ:ATRA
ATRA Forecast. What You Should Know.
ATRA Historical Ratings and Targets
About Atara Biotherapeutics
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company i... ATRA Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.